Search Results 981-990 of 16810 for astragalus dosage
Low dose steroids. Consent to pre-operative 10cc peripheral blood draw. Cohort 2: Women 18 years of age or older; Patients who have chosen to undergo a ...
Patients must have progressed on imatinib, sunitinib, and regorafenib or have documented intolerance to any of these treatments despite dose modifications.
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...
... dose of cabozantinib or sunitinib. The subject is ≥ 18 years old on the day of consent. The subject has an Eastern Cooperative Oncology Group (ECOG) ...
This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!